CLVT Stock Recent News

New Data Reveals Shifting Global Partnerships, Rising Open Access, and Focus on SDG-Aligned Research LONDON , July 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today published its annual G20 research and innovation scorecard, developed by expert analysts and data scientists at the Institute for Scientific Information (ISI) at Clarivate. This interactive scorecard offers a comprehensive, data-driven view of the research and innovation capabilities of G20 member nations.

LONDON , July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.

50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON , June 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports (JCR). This is the 50th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world's leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals' trustworthiness and impact.

New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth LONDON , June 16, 2025 /PRNewswire/ --  Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new Companies to Watch report, Radioligand Innovators Ushering in a New Era of Precision Oncology . The report spotlights pioneering companies that are redefining the drug discovery and development landscape through advancements in radioligand therapies (RLTs)—a rapidly evolving class of therapeutics that combines nuclear medicine with precision-targeted biotechnology to treat cancer with heightened specificity.

LONDON , June 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new milestone in its decades-long partnership with the American Library Association (ALA). Clarivate will be the first sponsor of the ALA Public Supporter Program, which engages the public in supporting libraries and library professionals.

Web of Science Provides Expanded Access to Essential Research Tools and Data for Canadian Libraries and Research Institutions LONDON , June 3, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a multi-year partnership with the Canadian Research Knowledge Network (CRKN), a consortium of libraries and research institutions in Canada. The agreement provides 55 Canadian universities with expanded access to the Web of Science and is designed to enhance inter-member research collaborations, improving accessibility to Web of Science content for all members.

LONDON , June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, announced today that it has successfully completed an incremental upsize of its term loan B credit facility. Pursuant to an amendment to the Company's existing credit agreement dated as of October 31, 2019, the Company incurred a new $500 million tranche of incremental term loans maturing in 2031, with an interest rate margin of 325 basis points per annum in the case of loans bearing interest by reference to term SOFR.

New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON , June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions.

New AI-based solution empowers trademark professionals to evaluate trademark risk and generate evidence-backed arguments with speed, ease, and confidence LONDON , May 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of RiskMark, an AI-powered solution combining global CompuMark trademark data and Darts-ip litigation data to evaluate trademark risk. Leveraging 172.5 million trademark records spanning 188 jurisdictions and over 5 million global court and administrative records, RiskMark combines generative and predictive AI to transform the process of assessing similarity risk based on relevant evidence.

Procter & Gamble, Nestlé, Apple, L'Oréal, Novartis, LG Electronics and Unilever among the largest portfolio owners in most registers LONDON , May 15, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Trademark filing trends 2025 report, analyzing ten key trademark registers worldwide: the United States (U.S.), Canada, the United Kingdom (U.K.), the European Union (EU), France, Germany, India, Mainland China, Japan, and Australia. The report reveals the top 20 largest local and foreign-based trademark portfolios in each region and the law firms managing the largest trademark portfolios.